Circulogene is a pure-play, commercial stage precision oncology diagnostics company with over 25,000 cancer patients tested to date using its liquid biopsy technology, Immunoclear and Tumorclear. Through its proprietary method, Circulogene is the only liquid biopsy company that can test for a cancer patient’s response to immunotherapy in blood, which is indicated for over 1 million new cancer diagnoses per year and the continuous recurrence of cancer.
